Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
NCT05687500Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glibenclamide in hyperglycemia, sponsored by Assistance publique - Hôpitaux de Paris. Started May 2023; status: completed.
02
Drugs
glibenclamide
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT05687500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687500.